company background image
BGT

Bio-Gene Technology ASX:BGT Stock Report

Last Price

AU$0.10

Market Cap

AU$18.8m

7D

-8.7%

1Y

-47.5%

Updated

05 Dec, 2022

Data

Company Financials
BGT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

BGT Stock Overview

Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia.

Bio-Gene Technology Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bio-Gene Technology
Historical stock prices
Current Share PriceAU$0.10
52 Week HighAU$0.35
52 Week LowAU$0.09
Beta0.51
1 Month Change-16.00%
3 Month Change-8.70%
1 Year Change-47.50%
3 Year Change-47.50%
5 Year Change-52.27%
Change since IPO-47.50%

Recent News & Updates

Recent updates

We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Feb 22
We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Oct 25
Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Jun 20
Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

Apr 28
Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

Jan 11
What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

Shareholder Returns

BGTAU ChemicalsAU Market
7D-8.7%-2.8%0.6%
1Y-47.5%2.9%-1.8%

Return vs Industry: BGT underperformed the Australian Chemicals industry which returned 2.9% over the past year.

Return vs Market: BGT underperformed the Australian Market which returned -1.8% over the past year.

Price Volatility

Is BGT's price volatile compared to industry and market?
BGT volatility
BGT Average Weekly Movement13.5%
Chemicals Industry Average Movement10.0%
Market Average Movement9.0%
10% most volatile stocks in AU Market15.9%
10% least volatile stocks in AU Market4.1%

Stable Share Price: BGT is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 13% a week.

Volatility Over Time: BGT's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
1995n/aRichard Jaggerhttps://www.bio-gene.com.au

Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production.

Bio-Gene Technology Limited Fundamentals Summary

How do Bio-Gene Technology's earnings and revenue compare to its market cap?
BGT fundamental statistics
Market CapAU$18.80m
Earnings (TTM)-AU$2.91m
Revenue (TTM)AU$445.73k

42.3x

P/S Ratio

-6.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BGT income statement (TTM)
RevenueAU$445.73k
Cost of RevenueAU$223.63k
Gross ProfitAU$222.10k
Other ExpensesAU$3.14m
Earnings-AU$2.91m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.016
Gross Margin49.83%
Net Profit Margin-653.81%
Debt/Equity Ratio0.0%

How did BGT perform over the long term?

See historical performance and comparison